Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review.
Neurosci Biobehav Rev
; 126: 175-193, 2021 07.
Article
en En
| MEDLINE
| ID: mdl-33497784
The increasing legal availability of cannabis has important implications for road safety. This systematic review characterised the acute effects of Δ9-THC on driving performance and driving-related cognitive skills, with a particular focus on the duration of Δ9-THC-induced impairment. Eighty publications and 1534 outcomes were reviewed. Several measures of driving performance and driving-related cognitive skills (e.g. lateral control, tracking, divided attention) demonstrated impairment in meta-analyses of "peak" Δ9-THC effects (p's<0.05). Multiple meta-regression analyses further found that regular cannabis users experianced less impairment than 'other' (mostly occasional) cannabis users (pâ¯=â¯0.003) and that the magnitude of oral (nâ¯=â¯243 effect estimates [EE]) and inhaled (nâ¯=â¯481 EEs) Δ9-THC-induced impairment depended on various factors (dose, post-treatment time interval, the performance domain (skill) assessed) in other cannabis users (p's<0.05). The latter model predicted that most driving-related cognitive skills would 'recover' (Hedges' g=-0.25) within â¼5-hs (and almost all within â¼7-hs) of inhaling 20â¯mg of Δ9-THC; oral Δ9-THC-induced impairment may take longer to subside. These results suggest individuals should wait at least 5â¯-hs following inhaled cannabis use before performing safety-sensitive tasks.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Fumar Marihuana
/
Disfunción Cognitiva
Tipo de estudio:
Prognostic_studies
/
Systematic_reviews
Límite:
Humans
Idioma:
En
Revista:
Neurosci Biobehav Rev
Año:
2021
Tipo del documento:
Article
País de afiliación:
Australia